Your browser doesn't support javascript.
loading
Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients.
Noce, Annalisa; Albanese, Maria; Marrone, Giulia; Di Lauro, Manuela; Pietroboni Zaitseva, Anna; Palazzetti, Daniela; Guerriero, Cristina; Paolino, Agostino; Pizzenti, Giuseppa; Di Daniele, Francesca; Romani, Annalisa; D'Agostini, Cartesio; Magrini, Andrea; Mercuri, Nicola Biagio; Di Daniele, Nicola.
Afiliación
  • Noce A; UOC of Internal Medicine-Center of Hypertension and Nephrology Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Albanese M; Neurology Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Marrone G; UOC of Internal Medicine-Center of Hypertension and Nephrology Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Di Lauro M; PhD School of Applied Medical, Surgical Sciences, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Pietroboni Zaitseva A; UOC of Internal Medicine-Center of Hypertension and Nephrology Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Palazzetti D; UOC of Internal Medicine-Center of Hypertension and Nephrology Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Guerriero C; UOC of Internal Medicine-Center of Hypertension and Nephrology Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Paolino A; UOC of Internal Medicine-Center of Hypertension and Nephrology Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Pizzenti G; Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Di Daniele F; School of Specialization in Geriatrics, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Romani A; UOC of Internal Medicine-Center of Hypertension and Nephrology Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • D'Agostini C; PhD School of Applied Medical, Surgical Sciences, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Magrini A; PHYTOLAB (Pharmaceutical, Cosmetic, Food Supplement, Technology and Analysis), DiSIA, University of Florence, Sesto Fiorentino, 50019 Florence, Italy.
  • Mercuri NB; Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Di Daniele N; Laboratory of Clinical Microbiology, Policlinico Tor Vergata, 00133 Rome, Italy.
Pharmaceuticals (Basel) ; 14(4)2021 Apr 06.
Article en En | MEDLINE | ID: mdl-33917573
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Pharmaceuticals (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Pharmaceuticals (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza